Free Access
Med Sci (Paris)
Volume 23, Number 11, Novembre 2007
Page(s) 1029 - 1031
Section Nouvelles
Published online 15 November 2007
  1. Blanc JF, Lalanne C, Plomion C, et al. Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 2005; 5 : 3778–89. [Google Scholar]
  2. Shen X, Mizuguchi G, Hamiche A, et al. A chromatin remodelling complex involved in transcription and DNA processing. Nature 2000; 406 : 541–4. [Google Scholar]
  3. Ikura T, Ogryzko VV, Grigoriev M, et al. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 2000; 102 : 463–73. [Google Scholar]
  4. Puri T, Wendler P, Sigala B, et al. Dodecameric structure and ATPase activity of the human TIP48/TIP49 complex. J Mol Biol 2007; 366 : 179–92. [Google Scholar]
  5. Bauer A, Chauvet S, Huber O, et al. Pontin52 and reptin52 function as antagonistic regulators of beta-catenin signalling activity. EMBO J 2000; 19 : 6121–30. [Google Scholar]
  6. Wood MA, McMahon SB, Cole MD. An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc. Mol Cell 2000; 5 : 321–30. [Google Scholar]
  7. Kim JH, Kim B, Cai L, et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature 2005; 434 : 921–6. [Google Scholar]
  8. Rousseau B, Ménard L, Haurie H, et al. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma. Hepatology 2007; 46 : 1108–18. [Google Scholar]
  9. Weiske J, Huber O. The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF-beta-catenin-mediated transcription. J Cell Sci 2005; 118 : 3117–29. [Google Scholar]
  10. Cho SG, Bhoumik A, Broday L, et al. TIP49b, a regulator of activating transcription factor 2 response to stress and DNA damage. Mol Cell Biol 2001; 21 : 8398–413. [Google Scholar]
  11. Talantov I, Mazumder A, Yu JX, et al, Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 2005; 11 : 7234–42. [Google Scholar]
  12. Graudens R, Boulanger V, Mollard C, et al, Deciphering cellular states of innate tumor drug responses. Genome Biol 2006; 7 : R19. [Google Scholar]
  13. Sanchez-Carbayo C, Socci ND, Lozano J, et al. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 2006; 24 : 778–89. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.